The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2007;356(23):2437.

Correspondence
PreviousPrevious
Volume 356:869-872 February 22, 2007 Number 8
NextNext

Left Ventricular Assist Devices and Drug Therapy in Heart Failure

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
-Related Article
-Related Article
 by Birks, E. J.
-PubMed Citation
To the Editor: The article by Birks et al. (Nov. 2 issue)1 is an important contribution to further development of a therapeutic approach to idiopathic dilated cardiomyopathy that remains controversial despite being repeatedly proved.2,3,4 The high recovery rate reported by the authors is encouraging, although it might have been facilitated by patient selection. Thus, Patient 11, with a small left ventricle and normal cardiac index value, underwent implantation of a left ventricular assist device with the diagnosis of idiopathic dilated cardiomyopathy. The survival rate after explantation in the study cohort (81.8% at 4 years) is similar to that among our . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.